Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes
BACKGROUND: The TMPRSS2:ERG gene fusion and PTEN loss are two of the most common somatic molecular alterations in prostate cancer. Here, we investigated the association of prediagnostic-circulating metabolomics and prostate cancer defined by ERG or PTEN status to improve understanding of these etiol...
Main Authors: | Feng, Xiaoshuang, Zhou, Cindy Ke, Clish, Clary B, Wilson, Kathryn M, Pernar, Claire H, Dickerman, Barbra A, Loda, Massimo, Finn, Stephen P, Penney, Kathryn L, Schmidt, Daniel R, Heiden, Matthew G Vander, Giovannucci, Edward L, Ebot, Ericka M, Mucci, Lorelei A |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research (AACR)
2021
|
Online Access: | https://hdl.handle.net/1721.1/138495 |
Similar Items
-
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes
by: Feng, Xiaoshuang, et al.
Published: (2022) -
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
by: Dickerman, Barbra A., et al.
Published: (2020) -
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
by: Barbra A. Dickerman, et al.
Published: (2020-03-01) -
Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer
by: Graff, Rebecca E., et al.
Published: (2022) -
Height, obesity, and the risk of TMPRSS2:ERG -defined prostate cancer
by: Graff, Rebecca E, et al.
Published: (2021)